DEPLOYDatabase

Robot model

Aletta

serviceresearchby Vitestro

Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion,…

Track Aletta
Manufacturer
Vitestro
Form factor
service
Maturity
research
Lifecycle
active
Deployments
1
Website
vitestro.com ↗

The verified answer

As of Oct 2026, DEPLOY verifies Aletta, a service by Vitestro (research): 1 verified deployment on record. 3 sources back the record.

Overview

Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion, and collect diagnostic blood samples; clinical trials reported about 94.5% first-stick success, with EU MDR approval.

Verified vs. claimed

Maturity stage
research(Lab-stage only; no commercial or public deployment reported.)
Sources on file
View all sources →

Key facts

Autonomy level

Autonomous

Sensor suite

AI and ultrasound imaging

First-stick success

~94.5%

Regulatory approval

EU MDR

End-to-end robotic blood draw

Vitestro describes Aletta as an autonomous device that identifies a vein, inserts the needle, and collects blood into tubes for diagnostic testing (Vitestro Aletta).

US authorization

The FDA announced De Novo authorization for Vitestro's autonomous robotic blood-draw device, the first of its kind authorized for the stated outpatient use (FDA robotic blood draw).

Specs

Class

autonomous robotic phlebotomy device

Success

~94.5% first-stick

Data & sources

Government records

1

Web sources

2

3 sources backing this record.View all →

Autonomy: verified vs claimed

What it actually does
Autonomous

Pricing

No verified price is on record for Aletta. Physical-AI systems are often sold through enterprise contracts or operated as a service rather than at a public list price.

How DEPLOY tracks pricing

Deployments (1)

Free to use on your site, with a link back to DEPLOY.

Aletta on the deployment map

View the global map

Where Aletta is verified operating. Explore the deployment map by place and type.

Free to use on your site, with a link back to DEPLOY.

Recent activity

Every change to this record is dated, sourced, and independently verified where marked.

Full change history →

Safety record

No incidents on record for Aletta.

Only active incidents are counted. Retracted incidents are excluded from this summary but remain reachable at their canonical URLs.

Sources (3)

  1. https://vitestro.com/aletta/
  2. https://www.fda.gov/news-events/press-announcements/fda-authorizes-first-its-kind-robotic-blood-draw-device
  3. https://www.instagram.com/reel/Dd4S8z6gytB/ · 2026-09-29

Common questions

What is Aletta?
Aletta is Vitestro's autonomous robotic phlebotomy device, combining AI, ultrasound imaging, and robotics to identify a suitable vein, guide needle insertion, and collect diagnostic blood samples; clinical trials reported about 94.5% first-stick success, with EU MDR approval.
How much does Aletta cost?
Aletta's price is not publicly disclosed. DEPLOY has no verified price on record for Aletta from Vitestro. Physical-AI systems like this are often sold through enterprise contracts or operated as a service rather than at a public list price; check the manufacturer for the latest.
Is Aletta actually deployed in the real world?
Yes. Aletta is independently verified in real-world operation on the DEPLOY registry, confirmed at named deployment sites with primary sources: not a concept, render, or demo-only.
Who makes Aletta?
Aletta is made by Vitestro, based in Nieuwegein, Netherlands.
Where is Aletta deployed?
1 verified deployment of Aletta is on the DEPLOY registry, including at Nieuwegein, Netherlands.
Can you buy Aletta?
Aletta is at research stage and is not yet available for sale.
What are alternatives to Aletta?
On the DEPLOY registry, comparable service robots to Aletta include Tally, Locus Origin, Moxi, Mirokai.
How does Aletta compare to Tally?
Aletta and Tally (Simbe Robotics · 16 deployments) are both service robots on the DEPLOY registry. Aletta has 1 verified deployment on record. Compare both records for specs, safety, deployments, and verified-vs-claimed autonomy.
Is Aletta a top service?
On DEPLOY's intelligence score, which blends verified deployments, safety, adoption, media, and IP signals, Aletta ranks in roughly the top 46% of service models tracked by the registry.
What is Aletta's maturity stage?
Aletta is at the research stage on the DEPLOY maturity ladder (research, prototype, pilot, commercial, production). Research stage means active development without commercial deployments on file.
Is Aletta safe?
Aletta has no incidents on record in the DEPLOY registry. This does not constitute a safety guarantee; it reflects the incidents DEPLOY has tracked and verified to date.
Methodology: Verified · 3 sources (1 primary) · last reviewed 2026-09-30

Verification posture

Verified

High confidence

Review state

Stable

Last reviewed 2026-09-30

Maturity + lifecycle

Maturity stage: research

Lifecycle: active

Architectural position

Cohort: service

Sources by quality tier

2
unclassified
Unclassified source
1
primary-fda-database
FDA database

The framework is documented at /methodology. Corrections at /corrections. Reviewer: DEPLOY editorial team.

Methodology surface for Aletta.

Recent coverage

Aletta in third-party press

How Vitestro’s first-of-its-kind Aletta robot autonomously draws blood

Sep 1, 2026

Vitestro raises 0M to ready blood collection robot for US launch

Jun 1, 2025

Vitestro Unveils Aletta: The World's First Autonomous Robotic Phlebotomy Device

Jun 1, 2025